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defibrillators due to firmware problems between 1990 and 2000 affected over 200,000 devices,
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software. To this effect, a real-time Virtual Heart Model (VHM) has been developed to model the
electrophysiological operation of the functioning (i.e. during normal sinus rhythm) and malfunctioning
(i.e. during arrhythmia) heart. We present a methodology to extract timing properties of the heart to
construct a timed-automata model. The platform exposes functional and formal interfaces for validation
and verification of implantable cardiac devices. We demonstrate the VHM is capable of generating
clinically-relevant response to intrinsic (i.e. premature stimuli) and external (i.e. artificial pacemaker)
signals for a variety of common arrhythmias. By connecting the VHM with a pacemaker model, we are
able to pace and synchronize the heart during the onset of irregular heart rhythms. The VHM has also
been implemented on a hardware platform for closed-loop experimentation with existing and virtual
medical devices. The VHM allows for exploratory electrophysiology studies for physicians to evaluate
their diagnosis and determine the appropriate device therapy. This integrated functional and formal
device design approach will potentially help expedite medical device certification for safer operation.
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Abstract—Designing bug-free medical device software is difficult, especially in complex implantable devices that may be
used in unanticipated contexts. Safety recalls of pacemakers and
implantable cardioverter defibrillators due to firmware problems
between 1990 and 2000 affected over 200,000 devices, comprising
41% of the devices recalled and are increasing in frequency [1].
There is currently no formal methodology or open experimental
platform to validate and verify the correct operation of medical
device software. To this effect, a real-time Virtual Heart Model
(VHM) has been developed to model the electrophysiological
operation of the functioning (i.e. during normal sinus rhythm)
and malfunctioning (i.e. during arrhythmia) heart. We present a
methodology to extract timing properties of the heart to construct
a timed-automata model. The platform exposes functional and
formal interfaces for validation and verification of implantable
cardiac devices. We demonstrate the VHM is capable of generating
clinically-relevant response to intrinsic (i.e. premature stimuli) and
external (i.e. artificial pacemaker) signals for a variety of common
arrhythmias. By connecting the VHM with a pacemaker model,
we are able to pace and synchronize the heart during the onset of
irregular heart rhythms. The VHM has also been implemented on
a hardware platform for closed-loop experimentation with existing
and virtual medical devices. The VHM allows for exploratory
electrophysiology studies for physicians to evaluate their diagnosis
and determine the appropriate device therapy. This integrated
functional and formal device design approach will potentially help
expedite medical device certification for safer operation.

I.. I NTRODUCTION
The heart is one of the most fundamental and important
natural real-time systems. The heart spontaneously generates
electrical impulses which organize the sequence of muscle contractions during each heart beat and are essential for optimizing
the cardiac stroke volume. The pattern and the timing of these
impulses determine the heart rhythm. Derangements in this
rhythm impair the heart’s ability to pump enough blood to meet
the body’s demand. Thus, the heart’s electrical system and its
timing, also known as its electrophysiological operation, are
fundamental to the cardiac function.
The use of artificial implantable heart rhythm devices such
as pacemakers and cardioverter-defibrillators has grown rapidly
over the recent decades and have demonstrated over 99%
efficacy for patients with cardiac arrhythmias or abnormal
heart rhythm. In the 20-year period from 1985 to 2005, the
US Food and Drug Administration’s (FDA) Maude database
records almost 30,000 deaths and almost 600,000 injuries from
device failures [2]. There is currently no formal methodology
or open experimental platform to validate and verify the correct
operation of medical device software. The FDA has expressed
the need for rigorous real-time methodologies to validate and
verify medical device software as is currently done in the
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domains of avionics and industrial control automation [3].
Medical devices are inherently Cyber-Physical Systems
where the control and computation within the device is tightly
coupled with the sensing and actuation of the biological physical substrate (i.e. the heart). It is therefore essential to model the
functioning of the device within the physical environment. The
relation between the physical state and the device state is largely
non-deterministic, interactive and cannot be fully captured by
computation models. The modeling of the physical substrate
must therefore be restricted to specific cases and conditions of
operation. Thus, the validation and verification observations are
only valid for those specific cases.
To address this need, a Virtual Heart Model (VHM) has
been developed to emulate the heart’s electrophysiological
operation for specific common arrhythmias. The VHM exposes
functional and formal interfaces for validation and verification
of implantable cardiac devices, as shown in Fig. 1. In this
investigation, we present a methodology to extract timing
properties of the heart to construct a timed-automata model. The
functional model is then validated by comparing the behavior
of the VHM to three common cases of normal and abnormal
heart rhythm. These cases are observed in real patients due to
failure of impulse generation and failure of impulse propagation. The clinical relevance of the electrogram outputs from
the model have been validated for these specific cases by an
electrophysiologist.
Now that the VHM has been validated, we are in the
position to validate and verify medical devices in closedloop operation with the VHM. We designed and validated
the functional pacemaker model for the two most frequent
arrhythmias. The formal model of the pacemaker was designed
and verified within the context of the VHM using Simulink
Design Verifier [4]. Following this, an initial version of the
VHM was implemented on a FPGA-based hardware platform
and the pacemaker was implemented on a microcontroller-based
platform for closed-loop experimental evaluation.
The primary contribution of this effort is the development
of an integrated functional and formal device design approach
which has the potential to help expedite medical device certification for safer operation. In addition, the VHM allows for
exploratory electrophysiology studies for physicians to evaluate
their diagnosis and determine the appropriate device therapy.
A.. Functional and Formal Modeling of the Heart
The functional and formal interfaces of the VHM are derived
from the common kernel. The kernel models the cardiac action

Figure 1.

Structure of the VHM platform

potential which is a principal phenomena of the heart’s conduction system. This allows us to model the heart as a network
of nodes, which are abstractions of localized electrically active
tissue. Conduction between nodes is modeled by paths with
know propagation and timing behavior. The functional model
emulates the behavior of the heart and allows validation through
simulation and black-box testing of the implantable devices.
We designed the kernel using the timed automata
approach[5] as the timing of the heart’s electrical system is
fundamental to the cardiac function[6]. While several cellularbased heart models exist [7], [8], [9], [10] they are useful for
simulation only and not for software verification. By simplifying the continuous system to an event-based timed automata
we are able to both simulate and verify the closed-loop system
for specific cases of interest.
B.
. Organization of the paper
The rest of the paper is organized as follows: In Section II,
we describe the VHM and the method in which the timing parameters are extracted. Section III provides medical validation
of the VHM. In Section IV, we introduce the pacemaker model
and its closed-loop evaluation. Finally, Section V describes an
FPGA implementation of the VHM along with the closed-loop
hardware setup used for pacemaker validation.
II.. VHM P LATFORM

different types of arrhythmias like Tachyarrhythmias (abnormally fast heart rate) and Bradyarrhythmias (abnormally slow
heart rate), which require medical intervention in the form of
medication, surgery, or an implantable device.
The electrical signal that passes through the heart is known
as an action potential. A typical ventricular action potential
is shown in Fig. 3(a). The action potential is triggered by
a voltage spike from the action potential of its neighboring
tissue or from an artificial pacing signal. The upstroke indicates
the depolarization of the cell and the time when the muscle
contracts. This is followed by the plateau, which allows the
muscle to hold its contraction and fully eject blood. The downstroke is repolarization, when the muscle relaxes and refills.
The total refractory period is the amount of time it takes for
an excited cell to be ready for a second stimulus once it returns
to its resting state. This can be divided into two time periods, the
effective refractory period (ERP) and relative refractory period
(RRP). The cell cannot be activated by an electrical stimulus
in the ERP, which acts as a blocking interval. In the RRP, the
cell can be activated again, but this causes changes in action
potential morphology. Changes in the duration of the plateau
will change the duration of the next ERP. A more gradual
upstroke of depolarization will slow the conduction velocity
of the tissue, as it will take more time to reach the voltage
threshold necessary to trigger a neighbor to depolarize. Thus,
the shape and timing of the action potential determines the
conduction velocity, and refractoriness of the heart.
The electrical activity of the heart can be monitored externally by an electrocardiogram (ECG) or internally, using
electrograms (EGM). The ECG measures the voltage difference
between two leads placed on the skin of the torso and provides
a general view of the electrical activities of the heart. The
electrogram signal is recorded from electrodes embedded in
a catheter placed on the inside surface of the heart. It is a
representation of local electrical activities of the heart. The
EGMs are useful in diagnosing cardiac arrhythmias for their
capability of localizing the source of activation[11]. Similar
electrodes are embedded in the leads of a pacemaker or implantable cardioverter-defibrillator (ICD).

A.
. The Cardiac Electrical System

B.. Timing Model of the VHM

In order to better understand the operation of the heart, we
provide some background. The human heart maintains blood
circulation of the body by coordinated contraction of the atria
and ventricles. Fig. 2(a) shows the essential elements of the
electrical conduction system of the heart. The electrical signal
originates from specialized tissue in the sinoatrial (SA) node,
which serves as the primary pacemaker of the heart. The SA
node spontaneously produces an electrical signal, which is
conducted radially through both atria, causing them to contract.
The signal then passes through the slow conducting AV node,
allowing blood to empty out of the atria and fill the ventricles.
The fast-conducting His-Purkinje system spreads the electricity
through the ventricles, causing all of the tissue in both ventricles
to contract simultaneously and force blood out of the heart
[6]. This electrical system provides organized contraction of
the heart muscle and optimizes hemodynamics. Abnormalities
in the electrical signal generation and propagation can cause

Modeling individual cells in order to obtain a global view of
the heart is processor heavy and contains extraneous information for purposes of device testing. Instead, our model utilizes
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(a) The basic physiology and electrical conduction system
of the heart. (b) Corresponding setup of nodes (dots), paths (lines) and
probes (shapes) in our heart model.
Figure 2.
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(a)Top: Surface ECG, Bottom: Action potential recorded from ventricular tissue. The dashed lines show how action potential
morphology changes when an early stimulus is applied to the tissue and how their corresponding timer values change in our model.(b)Node
automaton. (c)Path automaton

Figure 3.

the timing properties of the heart to obtain a macro-level view
by lumping cells into node automaton and path automaton.
The heart can be represented as a conduction network
(Fig. 2(b)), because activation of heart tissue can only trigger
its neighboring tissue. On a conduction path from tissue A to
tissue B, a stimulus cannot reach B if A is in ERP, even if B is
in the rest state. This is referred to as the functional refractory
period (FRP) of B. We can use this idea to model a section of
tissue as two node automata connected by one path automaton.
The refractory properties of the component are represented by
the nodes and the conduction properties between the nodes are
modeled by the path. We can represent different structures of
the heart by varying the parameters of the nodes and paths.
The basic state transitions of the node automaton and the
path automaton are shown in Fig. 3(b) and Fig. 3(c). In node
automaton, the refractoriness is modeled as ERP, RRP and Rest
states, and their durations are modeled by the timers Terp , Trrp ,
and Trest . The default refractory parameters we are using are (in
msec): ERP atrium:150-300; ERP AV node:230-400; ERP HisPurkinje:300-400; ERP Ventricle:180-290. These parameters
are tuned in relation to the true refractory periods measured
in clinical EP studies[12]. This allows us to produce clinicallyrelevant results. In path automaton, the conduction properties
are modeled as no conduction (Idle), antegrade conduction or
forward conduction (Ante), retrograde conduction or backward
conduction(Retro), both direction conduction (Double) and conflict (Conflict) state, and the conduction delays are modeled by
the timers Tante and Tretro .
It has been studied in [13] that action potential duration is
nearly logarithmically dependent on the timing of stimuli. We
made a first order approximation of the trend to create similar
behavior. In addition, the portion of total refractory period that
is in ERP is dependent on the amplitude of the stimuli. In our
model, we assumed a fixed amplitude for all the stimuli for
simplification, which is true in most implantable devices.
For the node automata in our model, the default value of its
Terp timer is determined by the earliness of a stimulus when it is
applied to the node. The earliness, Cearly , is a factor between 01, which is a measurement of how early the stimulus is applied
to the node before its Rest state (Eq. 1). For each node, the
min max
default value of Terp has a range [Terp
,Terp ]. The equation
for ERP default timer value Terp of node automata is shown in
Eq. 3. For nodes in atria, His-Purkinje system and the ventricle,

when the earliness increases, the default value of Terp decreases
slowly at first and abruptly when the earliness is around 1. The
trend is similar to the result in[13]. The AV node has a opposite
trend where Terp increases when the earliness increases, which
matches the result in[12]. The earliness of the stimulus also
determines the conduction velocity of its neighboring paths.
The conduction delays, which are the default values of
Tante and Tretro timers in our model, range from the ratio
of path length/conduction velocity to 4 times of this value.
The equations for forward conduction delay and backward
conduction delay are shown in Eq. 5 and Eq. 6 respectively.
For all heart tissues except the AV node, the conduction delay
increases slowly at first as the earliness increases and changes
abruptly when the earliness approaches 1. For the AV node the
relationship is linear, which increase faster than other tissue.
The equations that we used for adaptive ERP and conduction
velocities are shown below:

 0, s = ERP
Crrp , s = RRP
(1)
Cearly =

1, s = Rest
where Crrp is the ratio between current RRP timer value of the
ith node and its default
 value when3 the node is activated
(1 − Cearly ) , i = AV node
i
(2)
Cerp =
3
Cearly
, i 6= AV node
i
min
i
max
min
Terp
= Terp
+ b(1 − Cerp
) · (Terp
− Terp
)c

(3)

min
max
where Terp
and Terp
are minimal and maximal value of the
default value of ERP timer.

1 + 3Cearly , i = AV
i
Ccond
=
(4)
2
1 + 3Cearly
, i 6= AV
i→j
i
Tante
= bante del · Ccond
c

where ante del = path length/Vante .
i→j
j
Tretro
= bretro del · Ccond
c

(5)
(6)

where retro del = path length/Vretro .
The state transitions of node automaton and path automaton
are shown below:
1. Node automata state transitions
- Received activation signal at node
• In Rest state: go to ERP state, calculate the value of Terp
(Eq. 3), reset the ERP timer, activate neighboring paths
and change the Tante or Tretro (Eq. 5- 6).

28ms

(a) Conduction delay:120ms

11ms

(b) Conduction delay:50ms

(c) Perpendicular probe configuration

For (a),(b) and (c), the left columns show the placement of probes in relation to the path; the middle columns show the functional
EGM, and right columns show the formal signal sensed by the probe.
Figure 4.

In ERP state: calculate Terp (Eq. 3), neighboring paths are
not activated.
• In RRP state: go to ERP state, activate neighboring paths,
calculate Terp (Eq. 3), and change the conduction velocity
of neighboring paths (Eq. 5- 6).
- No activation signal received at node
•

•

•
•

In Rest state: SA and AV nodes count down the Rest
timer, when the timer times out, activate itself, go to ERP
state, activate neighboring paths and change the conduction
speed of neighboring paths according to Eq. 5- 6. Other
nodes stay in Rest state.
In ERP state: count down ERP timer and go to RRP state
after the timer runs out.
In RRP state: count down RRP timer and go to Rest state
after the timer runs out.

2. Path automata state transitions: The path automata is
initially in an idle state until either of the nodes it connects
to is activated(Act 1 or Act 2). The path starts the antegrade
or retrograde conduction timer according to which node is
activated. After the antegrade or retrograde timer times out,
the path activates the node at the opposite end. Because this
node activates all paths it is connected to, the path where the
activation originated must go to Conflict state to prevent back
flow. If a path is already in antegrade or retrograde conduction
when a second activation signal enters from the opposite end,
the path enters the Double state. Both Ante and Retro timer
count down until the timers correspond to the same location
and the path goes to the Conflict state.
C.
. Functional and Formal VHM interface
Our platform provides two interfaces, a formal signal for
medical device software and a functional electrogram for real
device implementation (see Fig. 1).
We introduce probes into the model which are equivalent
to the electrodes on the catheters or pacemaker leads. These
unipolar probes generate synthetic electrograms by multiplying
all voltages by a Gaussian factor and summing them together.
The bipolar electrograms are the differences between electrode
pairs. The bipolar formal signal is generated by an AND
operation between the two unipolar formal signals. Fig. 4(a),
Fig. 4(b) and Fig. 4(c) demonstrate an activation signal traveling
from node 1 to node 2. Changes in electrogram morphology
and duration of corresponding formal signals can be seen with
different configurations of the probe pair and the different con-

duction delay of the path. The formal signal is used to interact
with medical device software running at a lower frequency.
D.. Simulink Implementation of the VHM
The general automata and probe set used in our simulations
is shown if Fig. 2(b). The probes are placed in specific areas
to capture key activation timing intervals in the heart. The Hisbundle electrogram (HBE) can record impulses from the atrium,
His-bundle, and ventricles, which is useful for measuring the
atrium-to-His conduction time (A-H interval). Fig. 5(a) shows
the simulation GUI we developed in Matab, where the heart
anatomy is superimposed on the automata network. The length
of paths are measured in pixels to provide a relative length
relationship between different heart structures. Users can track
the updated values of timers on the right side tables. The current
state of all the nodes and paths are visualized using different
colors, giving a more intuitive understanding of the simulation.
Users can view electrograms and deliver programmed pacing
in real-time. Fig. 5(b) shows the electrograms measured from
all probes placed in the model. The underlying node automata
and path automata are implemented in Simulink, as shown in
Fig. 6 and Fig. 7. We chose Simulink as both the functional
and formal models could be developed with a common kernel.
III.. M EDICAL VALIDATION OF VHM
In order to validate the function of the heart model, we
compare the behavior of the VHM to common arrhythmias seen
in real patients due to failure of impulse generation and propagation. The clinical relevance of the electrogram outputs from
the model have been validated by an electrophysiologist. In the
following cases, we illustrate how our model can reproduce
the underlying electrical activity of the cardiac phenomenon.
While these cases may seem rather detailed to the real-time
community they capture the fundamental behavior of the node
and path automatas.
A.. Case 1: Wenckebach-type A-V nodal response
This case illustrates the Wenckebach block. The conduction
through the AV node slows, causing the ERP to lengthen,
resulting in a dropped beat due to failure of propagation. This
case highlights the capability of VHM to mimic the behavior
of the AV node.
Electrophysiologists use atrial pacing to induce a Wenckebach block [14] where the signal fails to conduct from atria to
ventricles. During this study, the heart is paced at constant cycle

(a) Simulation environment along with the Pace panel
Figure 5.

(b) Synthetic electrogram

GUI environment

NodeAutomaton {Active=0;
Trest_cur = Trest_start;TERP_def=TERP_defs;
TERP_cur = TERP_start;
TRRP_cur = TRRP_start;
[(~inActive)&(TRRP_cur== 0)]
NdSt = 0;}
{TRRP_cur = TRRP_def;
NdSt = 0;}
Rest
2
on clk: Trest_cur = Trest_cur− 1;
[inActive]
{Trest_cur = Trest_def;
TERP_def = Terp_max;
TERP_cur = Terp_max;
NdSt = 1;}

2

[(~inActive)&(Trest_cur== 0)]
[(~inActive)&(TERP_cur== 0)]
{Trest_cur = Trest_def;
{TERP_cur = TERP_def;
Active = 1;NdSt = 0;}
NdSt = 0;}

2

[inActive]
{TERP_cur = Terp_min; 1
TERP_def = Terp_min;
NdSt = 2;}

RRP
on clk: TRRP_cur = TRRP_cur− 1;

1

ERP
ex: Active = 0;
on clk: TERP_cur = TERP_cur− 1;
on clk: NdSt = 0;
on clk: Active = 0;

Figure 6.

1

[inActive]
{ratio := TRRP_cur/TRRP_def;
TERP_def = Terp_min + ((Terp_max−Terp_min)*( 1−ratio)*(1−ratio)*(1−ratio));
NdSt = 3;
TERP_cur = TERP_def;
TRRP_cur = TRRP_def;}

Simulink design of node automata

length. As pacing cycle length shortens, the AV conduction
delay increases after each pacing signal until there is a dropped
beat in the ventricles (as shown in Fig. 8). This phenomena
occurs because the ERP lengthens if a stimulus arrives during
the RRP interval of the AV node. When the ERP becomes
longer than the cycle length, conduction is blocked (as shown
in Fig. 9). This is known as a dropped beat, after which the A-H
conduction time recovers and the cycle repeats. The behavior
of the ERP is captured in the VHM’s AV node automata.

velocity. The time between the BCL and the extrastimulus is the
coupling interval A1 − A2 . For long coupling intervals, there is
no apparent delay. When the coupling interval is short, it falls
on the RRP of the delayed node and causes delays downstream.
The most common delays are seen in the AV node. The total
refractory period of the AV node is longer than that of any
other node group, which causes an increase in conduction time
of the extrastimulus from the atrium to the His-bundle (A2 −H2 )

B.
. Case 2: Conduction Response to Atrial Extrastimuli
This case demonstrates conduction responses to atrial extrastimuli (premature stimuli), which is the most basic electrophysiological test to locate abnormalities in the heart’s conduction system. This case highlights the capability of our model
to simulate different responses to extrastimuli in the atrium.
Atrial extrastimuli testing is used to characterize different
sites of conduction delay and block in the heart. After a drive
train is used at constant basic cycle length (BCL), an extra stimulus is introduced with shorter cycle length to test conduction

Figure 8. Electrograms of induced Wenckebach block in a patient [12]. The
atria are stimulated with short cycle length of 350 msec. With each stimuli, the
A-H interval in the HBE increases until there are no H and V at (1) due to the
block in A-V node. The A-H interval then recovers and the cycle repeats.

2

PathAutomaton
{outActive1= 0 ;outActive2= 0 ;
forw_timer_cur = forw_timer_s;
bck_timer_cur = bck_timer_s;}
Idle
en: idle_st =

1;

1

[bck_timer_cur==

0 ]{bck_timer_cur=bck_timer_def;outActive1=

1 ;}

1

[inActive1]

2

AntegradeConduction
on clk : forw_timer_cur = forw_timer_cur−
on clk : outActive1= 0 ;
on clk : idle_st = 0 ;

1;

1
2

[inActive2]

DoubleSt
on clk : forw_timer_cur = forw_timer_cur−
on clk :bck_timer_cur = bck_timer_cur−

1;
1;
2

3
[(~inActive1)&&(inActive2)]
[forw_timer_cur==

0 ]{forw_timer_cur=forw_timer_def;outActive2=

1 ;}

[abs( 1 −forw_timer_cur/forw_timer_def−bck_timer_cur/bck_timer_def) < (
{forw_timer_cur=forw_timer_def;bck_timer_cur=bck_timer_def;}
Retro
on clk :bck_timer_cur = bck_timer_cur−
1;
1
on clk : outActive2= 0 ;
[bck_timer_cur==
2

0 ]{bck_timer_cur=bck_timer_def;outActive1=

1 ;}

0.9 /min_path_par)]

Conflict
ex: outActive2= 0 ;
ex: outActive1= 0 ;

[inActive1]

[forw_timer_cur==

0 ]{forw_timer_cur=forw_timer_def;outActive2=

1 ;}

{forw_timer_def = forw_timer_defs;
bck_timer_def = bck_timer_defs;}
[(NdStEx== 2 )&(idle_st)]
UpdateTable
1
[(NdStEx== 3 )&(~idle_st)]
{bck_timer_def =
3 *bac_param; bck_timer_cur = bck_timer_def;}
{bck_timer_def = (bac_param*(
1 +2 *ratioEx*ratioEx*ratioEx*ratioEx));}
[(NdStEx== 3 )&idle_st]
2
1
3
{bck_timer_def = (bac_param*(
1 +2 *ratioEx*ratioEx*ratioEx*ratioEx));
[(NdStEn== 2 )&(idle_st)]
Update
bck_timer_cur = bck_timer_def;}
{forw_timer_def =
2 *forw_param; forw_timer_cur = forw_timer_def;}
4
12
[(NdStEn==
1 )&(~idle_st)]{forw_timer_def = forw_param;}
11
[(NdStEn== 1 )&(idle_st)]{forw_timer_def = forw_param;forw_timer_cur = forw_timer_def;}
5
[(NdStEn== 3 )&(idle_st)]
[(NdStEn== 3 )&(~idle_st)]
{forw_timer_def = (forw_param*(
1 +2 *ratioEn*ratioEn*ratioEn*ratioEn));
10
{forw_timer_def = (forw_param*(
1 +2 *ratioEn*ratioEn*ratioEn*ratioEn));}
forw_timer_cur = forw_timer_def;}
89
[(NdStEx== 1 )&(idle_st)]{bck_timer_def = bac_param; bck_timer_cur = bck_timer_def;}

7

6 [(NdStEx== 1 )&(~idle_st)]{bck_timer_def = bac_param;}
[(NdStEn== 2 )&(~idle_st)]{forw_timer_def =

[(NdStEx== 2 )&(~idle_st)]{bck_timer_def =

Figure 7.

2 *forw_param;}

3 *bac_param;}

Simulink design of path automata

Figure 9. Electrograms of induced Wenckebach block in the heart model with
stimulus cycle length of 420 msec. The heart model also displays lengthening
in the A-H interval and block in A-V node. Rows 5 and 6 show the increase
in the ERP and conduction delay of A-V node.

Fig. 10. The His-bundle and ventricles are downstream from the
delay in the AV node, so the time between two His activations
(H1 − H2 ) and two ventricular activations (V1 − V2 ) become
longer. There are no delays between the His-bundle and the
ventricles, so the conduction time between these two nodes
(H2 − V2 ) does not change. By setting the refractory period
parameters so that the AV node has the longest total refractory
period, as shown in Table I, the heart model can generate similar
trends, as depicted in Fig. 11. When the extrastimulus occurs
during Trest of the AV node, there is no delay. However, when
the extrastimulus occurs early during the Trrp of the AV node,
the A2 − H2 interval lengthens dramatically.
C.
. Case 3: AV Nodal Reentry Tachycardia
Tachyarrhythmias are the cause of significant mortality. The
most common mechanism for these arrhythmias is a reentry
circuit. Case 3 uses a supraventricular tachycardia (SVT) known
as AV nodal reentry tachycardia (AVNRT) to demonstrate the

Figure 10. Response to atrial extrastimuli in a patient [12]. Drive train with
period 800 msec is used before the extrastimuli are introduced. Conduction
occurs without delay for longer coupling intervals. Significant AV nodal block
causes the increase in A2-H2 interval due to long refractory periods in the
AV node. The in V1-V2 and H1-H2 intervals increase because these nodes are
downstream from the AV node.

capability of our model. It captures the conduction properties of
paths and refractoriness of nodes. AVNRT can occur in patients
of all ages due to premature depolarization of the atria, and it
can be induced by rapid atrial pacing. In these patients there is
an extra path with slow conduction and short refractory period
in the AV node in addition to the normal fast path with long
refractory period Fig. 12. Normally, conduction cannot occur
through this slow path because signals from the fast and slow
Table I

D EFAULT TIMER VALUES FOR ATRIUM STIMULI RESPONSE
SIMULATION

Node Group
Atrium
AV node
His-Purkinje
Ventricle

ERP range(ms)
150-200
230-300
300-350
200-290

RRP(ms)
100
200
50
100

Figure 11.
700 msec.

Response in the heart model simulation, with drive train period

paths conflict. However, when the atria are activated early by
an extrastimuli, as in Fig. 12, AVNRT can be induced. The
simulation results from our heart model are shown in Fig. 13.

Figure 13. Induced AVNRT by extrastimuli pacing in the heart model. The
normal cycle length is 700 ms, and the extrastimuli occurs after only 380ms
at (1), causing a prolonged Ap-H interval (2) and inducing AVNRT, the fast
atrial rate causes a 2:1 conduction from A to V (see the CS electrogram (3)).
Position
Category

IV.. C LOSED L OOP M EDICAL D EVICE VALIDATION AND
V ERIFICATION
Now that the VHM has been validated, we are in the position
to validate and verify medical devices in closed-loop operation
with the VHM. The general framework for evaluating a medical
device within its operating environment is as follows: (a)
different modes of device operation are specified; (b) the device
functional model is developed and validated in the context of
the patient’s physiology; (c) the formal model is developed and
interfaced with the formal model of the patient; and finally (d)
an experimental evaluation is conducted between the patient
model and the implementation of the device.
In this study we specifically focus on the artificial pacemaker
device (hence forth referred as pacemaker). The pacemaker
was selected as it is a relatively simple device, which has
been widely used for a number of decades, and yet has been
subject to a large number of recalls. We designed and validated
the functional pacemaker model using the two most frequent
arrhythmias. The formal model of the pacemaker was designed
and verified within the context of the VHM using Simulink
Design Verifier[4] (Fig. 14). The results are applicable only to
the cases investigated and further results may be found in the
technical report[15].
A.
. Artificial Pacemaker
In order to better understand the need and the operation of
the pacemaker, we provide some background. Rhythm man-

Letters

I
Chambers
paced
O=none
A=atrium
V=ventricle
D=dual
(A&V)

II
Chambers
Sensed
O=none
A=atrium
V=ventricle
D=dual
(A&V)

III
Response
to sensing
O=none
T=triggered
I=inhibited
D=dual
(T&I)

IV
Programmability
rate, modulation
O=none
P=simple
programmable
M=multiprogrammable
C=communicating
R=rate modulation

V
Antiarrhythmia
functions
O=none
P=pacing
(antiarrhythmia)
S=shock
D=dual(P&S)

Table II
H EART R HYTHM S OCIETY - GENERIC PACEMAKER CODE

agement from a cardiac pacemaker is a necessary therapy for
patients with brady and tachyarrhythmias. The pacemaker leads
are implanted inside the patient’s heart in the wall of the atrium,
ventricle, or both chambers of the heart. Electrodes on the
lead can have both sensing and pacing abilities, depending
on the mode in which the pacemaker is operating. The Heart
Rhythm Society has developed a five-position code to describe
the modality of the pacemaker (Table II), though the first three
positions contain the most pertinent information. Position I
describes the pacing locations, position II describes the sensing
locations, and position II describes how the device responds to
sensing. The physician chooses the pacemaker mode based on
the location and nature of the patient’s specific arrhythmias.
B.. Pacemaker model
The pacemaker model has the capability to operate in any
mode, but specifically the AAI and DDD modes have been
implemented and tested with our heart model. AAI is single
chamber mode that provides demand pacing from an atrium
lead. If an intrinsic event is sensed by the lead, the pacing
function is inhibited; otherwise, it will pace the chamber.
This mode cannot ensure synchrony between the atrial and
ventricular rhythms, which can be problematic and lead to
pacemaker syndrome and inefficient pumping. DDD is a more
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Figure 12. AVNRT in different timing scenarios with the accessory pathway.
Each circuit is isolated in the AV node. Conduction at normal rhythm is shown
on the left, where the two signals conf lict in the slow pathway. 1, 2, and
3 show the progression towards AVNRT. Early activation reaches a block in
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Closed Loop Model in Simulink

pacemakerDDD
{LRIcur=LRIdef;
LRIout=0;}

LRI

LRI
on clk: LRIcur = LRIcur−1;
on clk: LRIout = 0;

1

AVI

5

{AVIout =0;}

[(LRIcur==0)||AVIout || VRPout]
{LRIcur=LRIdef; LRIout=0;}

1

[(AVIcur<=0)&&(URIst==1)]{AVIout =1;}
st1
2
on clk: AVIout=0;
ex: AVIout=0;
st2
en: AVIcur=AVIdef;
on clk: AVIcur = AVIcur−
1;
en: AVIst =1;
[LRIout||ARPout]
on clk: AVIout =0;
{AVIst=0;}

2

[(LRIcur==AVIdef)&&(AVIst==1)]{LRIout=1;LRIcur = LRIcur−1;}
[VRPout]{AVIout=0;}
VRP

VRPst1
en: VRPcur = VRPdef;

1

3

{VRPout=0;}
[Vin || AVIout]
{VRPout=Vin;}

VRPst2
on clk: VRPcur = VRPcur−1;
on clk: VRPout = 0;

{ARPout=0;
ARP ARPcur=ARPdef;}

2
[ARPcur == 0]{ARPcur =ARPdef;}

[VRPcur == 0]{VRPout=0;}
ARPs1
on clk: ARPout=0;

[AVIout||VRPout]
{ARPout=0;}

ARPs2
on clk: ARPcur = ARPcur−
1;

2

4

URI
[AVIout || VRPout]
{URIst = 0;}
URIst1
en: URIst=1;
en: URIcur = URIdef;

URIst2
on clk: URIcur = URIcur−1;

1

[Ain&&(AVIst==1)&&(~AVIout)&&(VRPout)]
{ARPout=1;}

2

[URIcur==0]

[(URIcur==0)&&(AVIcur<0)]
{AVIout =1;AVIcur=AVIdef;}

Figure 15.

1

Simulink Stateflow model of Pacemaker

sophisticated mode of operation and is implemented in dual
chamber pacemakers. The device can both sense and pace from
the atrium and the ventricle, which allows for synchronous
pacing and proper hemodynamics. The 5 basic timing cycles
of the DDD mode pacemaker are shown in Fig. 16[16]. In
our pacemaker model, we designed 5 corresponding software
components, shown in Fig. 15. These components run in
parallel and are triggered by events. We group the components
as follows:
1. Lowest Rate Interval (LRI) is the most basic timing
cycle and it is the only timing cycle in our AAI mode. This
component keeps the heart rate above a minimum value. The
LRI timer is reset after there is a sensed cardiac event (atrial
event in AAI mode and ventricular event in DDD mode). For
AAI mode, if no atrial event has been sensed (AS) before the
timer runs out, the pacemaker will deliver pacing signal from
the atrial lead (AP). For DDD mode, if no ventricular event has
been sensed (VS) before the timer runs out, the pacing signal
will be delivered from the ventricular lead (VP).
2. Atrio-Ventricular Interval (AVI) component only appears in dual chamber modes of pacemaker. The function of
this components mimic the intrinsic AV delay to synchronize
the atria and ventricle events. The timer is started by a sensed or
paced atrial event and can be terminated by a sensed ventricular
event. If no ventricular event is sensed before the timer times
out, the pacemaker will pace the ventricle.
3. Three auxiliary components which filter out noise and

early events which would otherwise cause undesired pacemaker
behavior. The post ventricular atrial refractory period (PVARP)
component is a blocking interval where atrial sensing cannot
occur. It mimics the atrial refractory period, during which no
atrial events should occur for proper function. The ventricular
refractory period (VRP) component is the blocking interval for
ventricular events. The upper rate interval (URI) component
provides an upper bound for ventricular pacing.
C.. Pacemaker Functional Model Validation
By simulating clinical cases where pacemaker therapy is
needed using our heart model and comparing the effects using
different modes of pacemakers, we demonstrate how our model
can be used to validate pacemaker design and help physicians to
determine an appropriate pacemaker mode. The following cases
are common arrhythmias and are considered clinically-relevant
by an electrophysiologist.
1). Case 1: Sinus Bradycardia: This is the most basic
arrhythmia that can be controlled by a pacemaker, where the
patient’s SA node fires at a rate less than 60 beats per minute.
Fig. 17 shows the heart model simulating a bradycardia event.
As the heart model is running, event (1) triggers the Trest
interval of the SA node to lengthen, causing bradycardia. When
the AAI pacemaker model interacts with the bradycardia heart
model, the device intervenes at event (1) and delivers pacing to
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Figure 17. Case 1: Sinus bradycardia without pacemaker. The figure shows
the atrial and ventricle electrograms recorded by the pacemaker model. The
heart model starts in Normal Sinus Rhythm (NSR), with beat-to-beat interval
of approximately 750 ms. Event 1 changes the Trest timer of SA node, causing
bradycardia with beat-to-beat interval stretched to 1100 ms. Event 2 changes
the same Trest to resume NSR.
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Case 1: Sinus bradycardia with AAI pacemaker. The bottom
panel shows the sensing and pacing state of the pacemaker model. At (1) the
pacemaker delivers a pacing stimulus(AP) when interval between two atrium
events is longer than LRI(1). At (2), pacing is inhibited by a sensed atrial event.

the atrium (Fig. 18). This pacing signal is conducted throughout
the heart and triggers a ventricular event, maintaining 1:1
conduction in the heart.
2)
. Case 2: Sinus Bradycardia with Second degree heart
block (Wenckebach type): A patient with bradycardia and
abnormal A-V conduction system was simulated in Fig. 19. The
mechanism of this kind of heart block was shown in Section
III. The EGM in Fig. 20 shows gradually increased AV delay
due to fast atrial pacing until there is a dropped beat. A DDD
mode pacemaker is shown to maintain a steady ventricular rate
(Fig. 21) and prevent the dropped beat.
In this subsection we validated our pacemaker model with
two most common arrhythmias requiring the assistance of the
pacemaker. We also showed that the heart model can be used
as a tool to assist cardiologists in selecting appropriate mode.
D.
. Formal Verification
The major benefit of the VHM is that the exposure of
the formal interface allows use of the formal methods for
verification of close-loop designs. Several verification tools are
available that can be used for checking of structural and safety
properties along with the test cases generation.
Simulink Design Verifier (SDV)[4] exploits a Prover technology based formal method proving engine. To prove a property
using SDV we created a Simulink sub-system that describes
a temporal condition that needs to be obtained by the signal.
For example, Fig. 22 shows a structure of the Verification
Subsystem from Fig. 14, which is used to verify property that
the pacemaker in DDD mode of operation will keep the right
ventricular inter-pacing interval between two consecutive beats,
in [0.9s, 1.1s] range (since in the pacemaker is modeled to work
with 1ms clock). Due to space limitations, more details about
other designed sub-systems can be found in [15].
UPPAAL[17] is a widely used tool for system verification,
where properties must be expressed using temporal logic formulas before they are checked. In order to use UPPAAL the
kernel of the VHM along with its formal interface have to be
ported from Stateflow to UPPAAL.
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Case 2: Sinus bradycardia with second degree heart block
(Wenckebach type) with AAI pacemaker. The coupling interval of the pacing
stimuli is shorter than the RRP of AV node, which lengthens the ERP and the
conduction delay of AV node until a dropped beat occurs in the ventricle. AAI
pacemaker cannot maintain ventricle rate

V.. P HYSICAL IMPLEMENTATION
The Virtual Heart Model (VHM) was implemented on Xilinx
Spartan-3, XC3S1000 FPGA [18]. The automatas described in
Section II were designed to work with a 10MHz clock. The
transition from Simulink/Stateflow design to VHDL description
was done manually although appropriate tools exist, which can
automatically extract VHDL code from Stateflow design ([19],
[20]). Since manual migration from Simulink to VHDL can be a
cause of discrepancy between two designs, the use of automatic
translators should be a part of future VHM models.
In order to demonstrate how the VHM model can be used for
closed-loop black-box testing of implantable medical devices,
we used a setup shown in Fig. 23. The pacemaker design
described in previous section was implemented on FireFly
sensor nodes [21]. The nodes run the nano-RK [22], realtime operating system developed with timeliness as a first-class
concern. On FireFlies, nano-RK operates with a 1ms OS tick.
The pacemaker was implemented on a FireFly node using
five tasks, corresponding to the automatas from Fig. 15, for the
ventricle-pace (LRI task), ventricle-sense (AVI task), atrialpace (ARP task), atrial-sense (VRP task) and a coordinator
between the atrium and ventrical leads (URI task). Each task
was assigned a period of 10ms . The priorities for the tasks
(along with equal offsets) are assigned to match the execution
order of the parallel states from Fig. 15 (lower value has greater
priority). This implementation, while not fully reflective of the
complexity of a modern pacemaker, is simple and allows the
evaluator to easily disable some of the tasks to test pacemakers
in any of the modes. In our initial setup of the implementation
we have been able to experimentally validate the closed loop
behavior of the system.
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Figure 19. Case 2: Sinus bradycardia with concealed second degree heart
block (Wenckebach type). Bradycardia with beat-to-beat intervals around 1200
ms produces 1:1 atrium to ventricle conduction.
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Figure 21. Case 2: Sinus bradycardia with second degree heart block (Wenckebach type) with DDD pacemaker. The pacemaker maintains the synchronization
between the atria and ventricles by pacing the ventricle(VP)
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VI.. R ELATED WORK
Researchers have tackled the problem of whole-heart modeling using a variety of different methods. Modern techniques are
capable of producing high-resolution techniques almost down to
the cellular level. Jalife et al [8] modeled the activity of single
ion channels in order to get a detailed description of a single
cell. This model can produce action potentials nearly identical
to physiological ones, but creating a full model of the heart
based on such details within single cells is not computationally
possible in real time. Harrild and Henriquez [9] designed a finite
element three dimensional mesh model with resolution close to
the cellular level. They were able to model the potentials across
both atria, but could not extend the model to the entire heart.
In order to accommodate the memory and time constraints
presented by current computing tools, empirical models are the
best solution to allow for full heart modeling. These models,
such as ones created by Adam [10] and Berenfeld et al. [7],
simplify the heart tissue and do not attempt computing on the
cellular level. Adam analyzed the wavefront of depolarization
within his cardiac model, but he was unable to recreate the
repolarization front, and thus he could not produce reentry
circuits and arrhythmias.
Formal methods have traditionally been used for verification
of time-critical and safety-critical embedded systems [23]. Until
recently these methods have not been used for medical device
certification. The authors in [24] presented the use of Extended
Finite State Machines for model checking of the Computer
Automated Resuscitation A medical device. Formal techniques
have also been applied to improve medical device protocols
([25]) and safety ([26]). However, the authors either used a
simplified patient model or did not model the patient at all.
VII.. C ONCLUSION
A primary challenge in life-critical real-time systems is
with the design of bug-free medical device software. While

Figure 23. Closed-loop experimental setup. Medtronic cardiac defibrillator
and pacemaker models are shown for reference.

implantable cardiac devices are being inserted into millions
of patients worldwide, the number of recalls due to firmware
problems are significant and growing in frequency. There is,
therefore, an urgent need for methodologies for medical device
certification within the context of the biological environment.
We present an integrated approach for medical device software
validation and verification with a focus on artificial cardiac
pacemakers. To this effect, a real- time Virtual Heart Model
(VHM) has been developed to model the electrophysiological
operation of the human heart and interfaces both functionally
and formally with a pacemaker model. This approach will
potentially help expedite medical device certification for safer
operation. The platform is available as a free and open source
platform to the research community.
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